Report of Neuromuscular Patients Diagnosed Using Whole Exome Sequencing in Qeshm Island

  • سال انتشار: 1398
  • محل انتشار: نوزدهمین کنگره سالانه اعصاب کودکان ایران
  • کد COI اختصاصی: CCNMED19_042
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 261
دانلود فایل این مقاله

نویسندگان

Pooneh Nikuei

Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Pooneh Nikuei

State Welfare Organization, Bandar Abbas, Iran.

Mojgan Saberi

National Institute of Genetic Engineering and Biotechnology Tehran, Iran.

Parnian Pourkashani

Iran University of Medical Sciences, Tehran, Iran.

Abdolmajid Nazemi Qeshmi

Assistant Professor, Pediatric, Pediatric Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

چکیده

Introduction: Neuromuscular disorders are clinically, pathologically and genetically heterogeneous group. Even for the experienced clinician, a definite diagnosis is oftenchallenging due to the complexity of these disorders. Accurate molecular genetic diagnosis can improve clinical management, provides appropriate genetic counseling andtesting of relatives, and allows potential therapeutic trials. Here, we investigated the utility of whole exome sequencing (WES) in early diagnosis of neuromuscular disordersin Qeshm Island. Method: Most patients had history of, neurodevelopmental delay, seizure, mental retardation, vision problems, dysmorphic face and congenital anomalies. Clinical Exmore sequencing, followed by diagnostic interpretation of variants in genes associated with NMDs, was performed for patients suspected to have a neuromuscular genetic cause. Results: From ۱۰ WES performed for patients with neuromuscular diseases ۳ variants were reported previously in other populations but ۶ variants were novel which diagnosed for the first time in Qeshm Island which were segregated in families. In one family with two affected child the genetic cause was not found. Conclusions: Whole exmoe sequencing is a useful tool for early diagnosis of Neuromuscular Disorders especially in regions with high consanguinity. Using this technique concerning the right indications could help in finding new genes responsible for neuromuscular disorders and could be effective in recognizing carriers and guiding them for prenatal iagnosis or PGD resulting in prevention of genetic neuromuscular disorders.

کلیدواژه ها

Exmoe Sequencing, Neuromuscular Disorders, Qeshm.

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.